Select Page
Responsive Centered YouTube Video
Concerns raised about the integrity of public health institutions and the vaccine industry due to mismanagement and corruption.
  • Technology limitations and mismanagement in targeting high-risk groups led to increased risks and exposure. 0:20

  • People affected by the technology will continue to speak out, potentially leading to the downfall of the platform and the vaccine enterprise. 0:57

  • Public faith in public health institutions like the CDC and FDA has been compromised, with accusations of corruption. 1:30

  • Historically trusted regulatory bodies like the FDA are now being viewed as unreliable and corrupt, impacting public perception in Europe. 1:55

Impact of rushed vaccine operation on US biopharmaceutical industry and global reputation.
  • US competitive position in biopharmaceuticals damaged, leading to import dependence on India and China. 2:57

  • Reputation of FDA globally tarnished due to emergency use authorization of unsafe products. 3:53

  • Initial overestimation of virus lethality by government officials, highlighting misinformation. 4:14

  • Trump’s early correct assessment of virus mortality rate contradicted initial projections. 4:41

Ethical breaches and lack of predictability in vaccine development processes raise concerns.
  • Initial beliefs of a highly lethal virus leading to extreme measures were based on false propaganda. 4:58

  • International norms of ethics and product development have been compromised in the rush for vaccines. 5:24

  • Colleagues in the industry are perplexed by the current state of vaccine development and regulatory affairs. 5:32

  • Regulatory processes in the US have become unpredictable and less structured, causing confusion among developers. 6:01

  • Integrity of the entire system is now at risk, with uncertainty on standards and potential corruption. 6:44